Comprehensive Detection of Respiratory Pathogens Using Next-Generation Sequencing
The IVDNGS™ Extended Respiratory Pathogen Panel is an advanced Next-Generation Sequencing (NGS)-based assay designed for the simultaneous detection and identification of a broad spectrum of viral, bacterial, and fungal pathogens directly from respiratory samples. Developed for in vitro diagnostic use, this panel enables accurate, sensitive, and high-throughput analysis of respiratory tract infections—including co-infections and rare pathogens—within a single test.
This solution is ideal for clinical diagnostics, outbreak investigations, ICU settings, and immunocompromised patient monitoring, offering detailed insights that go beyond conventional PCR and culture-based methods.
Broad pathogen coverage: Detects viruses, bacteria, fungi in one workflow
High sensitivity and specificity
Unbiased sequencing approach to detect known and emerging pathogens
Effective for co-infection and antimicrobial resistance analysis
Compatible with respiratory specimens like nasopharyngeal swabs, sputum, BAL
Integrated with advanced bioinformatics pipeline for clinical interpretation
Developed under ISO13485 and IVD compliance
Hospital-acquired and community-acquired respiratory infection diagnosis
Outbreak and epidemic surveillance (e.g., COVID-19 variants, influenza strains)
ICU-based infectious disease profiling
Detection of rare and atypical respiratory pathogens
Precision antimicrobial therapy guidance
| Pathogen Type | Examples |
|---|---|
| Viruses | Influenza A/B, RSV, Rhinovirus, Adenovirus, Human Metapneumovirus, SARS-CoV-2 |
| Bacteria | Streptococcus pneumoniae, Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae |
| Fungi | Aspergillus spp., Candida spp., Pneumocystis jirovecii |
Copyright © 2025 https://probgenbiotech.com/ All Rights Reserved.